Weizhu Wu
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Breast Cancer Treatment Studies
Papers in
-
- Cancer-related molecular mechanisms research 7
- Breast Cancer Treatment Studies 5
- MicroRNA in disease regulation 2
-
- RNA modifications and cancer 5
- RNA Research and Splicing 3
- Circular RNAs in diseases 3
- Co-authors
- Jinhua Ding (9 shared papers)Minhua Wu (6 shared papers)Li Jiang (3 shared papers)Yuxin Zhou (5 shared papers)Yimin Lu (1 shared paper)Elena López‐Camacho (1 shared paper)Tianxiang Chen (1 shared paper)Xiaoping Sun (1 shared paper)
In The Last Decade
Weizhu Wu
20 papers receiving 274 citations
Peers
Comparison fields: 5 of 51
- Cancer Research 141
- Oncology 65
- Pathology and Forensic Medicine 41
- Molecular Biology 152
- Genetics 45
Countries citing papers authored by Weizhu Wu
This map shows the geographic impact of Weizhu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weizhu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weizhu Wu more than expected).
Fields of papers citing papers by Weizhu Wu
This network shows the impact of papers produced by Weizhu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weizhu Wu. The network helps show where Weizhu Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Weizhu Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 42 | |
| 2 | 2014 | 30 | |
| 3 | 2019 | 26 | |
| 4 | 2017 | 25 | |
| 5 | 2020 | 23 | |
| 6 | 2019 | 21 | |
| 7 | 2023 | 16 | |
| 8 | 2023 | 15 | |
| 9 | 2020 | 14 | |
| 10 | 2017 | 14 | |
| 11 | 2018 | 12 | |
| 12 | 2019 | 11 | |
| 13 | 2022 | 7 | |
| 14 | A rare case of secretory breast carcinoma in a male adult with axillary lymph node metastasis. | 2015 | 5 |
| 15 | 2017 | 4 | |
| 16 | 2022 | 3 | |
| 17 | 2023 | 3 | |
| 18 | Validation of the Prognostic Stage from the American Joint Committee on Cancer 8th Staging Manual in Luminal B-Like Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer | 2022 | 2 |
| 19 | 2025 | 1 | |
| 20 | Clinical Efficacy of Neoadjuvant Chemotherapy plus Modified Radical Mastectomy for Stage II-III Breast Cancer Patients and Its Influence on Serum Tumor Markers. | 2024 | 1 |
About Weizhu Wu
Weizhu Wu is a scholar working on Cancer Research, Molecular Biology, Oncology, Pulmonary and Respiratory Medicine and Genetics, having authored 21 papers that have together received 275 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), Breast Cancer Treatment Studies (5 papers), RNA modifications and cancer (5 papers), HER2/EGFR in Cancer Research (3 papers), RNA Research and Splicing (3 papers), Circular RNAs in diseases (3 papers), Estrogen and related hormone effects (3 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (141 citations), Oncology (65 citations), Pathology and Forensic Medicine (41 citations), Molecular Biology (152 citations) and Genetics (45 citations). Weizhu Wu has collaborated with scholars based in China, Taiwan and Spain. Frequent co-authors include Jinhua Ding, Minhua Wu, Li Jiang, Yuxin Zhou, Yimin Lu, Elena López‐Camacho, Tianxiang Chen, Xiaoping Sun, Jiafeng Chen and Yu Gu. Their work appears in journals such as Frontiers in Oncology, Cancer, Scientific Reports, In Vitro Cellular & Developmental Biology - Animal and Clinical Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.